Is Silo Pharma Inc (SILO) overvalued? · rev $72.1K
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
This page asks whether Silo Pharma Inc (SILO) looks expensive on cached numbers — not a short thesis.
Latest reported SILO revenue for 2024-12-31 was $72.1K. Net income was -$4.4M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. SILO currently screens at market cap $4.4M.
SILO currently screens at market cap $4.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SILO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SILO stock page for the full model, not this heading.
Not investment advice.